Cyclooxygenase 2 inhibitors: discovery, selectivity and the future

Author： Marnett L.J.   Kalgutkar A.S.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.20, Iss.11, 1999-11, pp. : 465-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective inhibitors of cyclooxygenase-2

By Talley J.J.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 55-62

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Design of Selective Cyclooxygenase-2 Inhibitors as Non-Ulcerogenic, Anti-Inflammatory Drugs with Potential Utility as Anti-Cancer Agents

By  

Current Drug Targets, Vol. 2, Iss. 1, 2001-03 ,pp. : 79-106

Bentham Science Publishers

Access to resources Recommend Favorite

Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation

By Gilroy D.W.   Tomlinson A.   Willoughby D.A.  

European Journal of Pharmacology, Vol. 355, Iss. 2, 1998-08 ,pp. : 211-217

Elsevier

Access to resources Recommend Favorite

Potent and selective cyclooxygenase-2 inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 79-80

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of cyclooxygenase-2 and 5-lipoxygenase

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 1041-1042

Informa Healthcare

Access to resources Recommend Favorite